Early optimal nutrition improves neurodevelopmental outcomes for very preterm infants

Nutrition Reviews

Volumn 72, Issue 8, 2014, Pages 532-540

  Hsiao, Chien Chou ^a,b   Tsai, Ming Luen ^c   Chen, Chih Chen ^d,e   Lin, Hung Chih ^c  

^a CHANGHUA CHRISTIAN HOSPITAL   (Taiwan)

^b CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^c CHINA MEDICAL UNIVERSITY   (Taiwan)

^d CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^e CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

Author keywords

Lactoferrin; LCPUFA; Neonatal intensive care; Neurodevelopmental impairment; Preterm extremely low birthweight infants; Probiotics

Indexed keywords

AMINO ACID; GLUCOSE; LACTOFERRIN; LONG CHAIN FATTY ACID; LONG CHAIN POLYUNSATURATED FATTY ACID; POLYUNSATURATED FATTY ACID; PROBIOTIC AGENT; UNCLASSIFIED DRUG;

ARTICLE; DIET SUPPLEMENTATION; ENTERIC FEEDING; HUMAN; LIPID COMPOSITION; LUNG DYSPLASIA; MENTAL DISEASE; META ANALYSIS (TOPIC); NECROTIZING ENTEROCOLITIS; NERVE CELL DIFFERENTIATION; NEUROLOGIC DISEASE; NONHUMAN; NUTRIENT; NUTRITION; PARENTERAL NUTRITION; PERINATAL PERIOD; PREMATURITY; RANDOMIZED CONTROLLED TRIAL (TOPIC); RETROLENTAL FIBROPLASIA; SYSTEMATIC REVIEW (TOPIC);

ANIMALIA;

LACTOFERRIN; LCPUFA; NEONATAL INTENSIVE CARE; NEURODEVELOPMENTAL IMPAIRMENT; PRETERM EXTREMELY LOW-BIRTHWEIGHT INFANTS; PROBIOTICS;

ANIMALS; CHILD DEVELOPMENT; DIET; ENTEROCOLITIS, NECROTIZING; HUMANS; INFANT; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, VERY LOW BIRTH WEIGHT; LACTOFERRIN; MALNUTRITION; MILK, HUMAN; PARENTERAL NUTRITION; PROBIOTICS;

EID: 84905003179     PISSN: 00296643     EISSN: 17534887     Source Type: Journal    
DOI: 10.1111/nure.12110     Document Type: Article

References (110)

1. Horbar JD, Carpenter JH, Badger GJ, etal. Mortality and neonatal morbidity among infants 501 to 1500 grams from 2000 to 2009. Pediatrics. 2012;129:1019-1026.
2. Vohr BR, Stephens BE, Higgins RD, etal. Are outcomes of extremely preterm infants improving? Impact of Bayley assessment on outcomes. J Pediatr. 2012;161:222-228.
3. Franz AR, Pohlandt F, Bode H, etal. Intrauterine, early neonatal, and postdischarge growth and neurodevelopmental outcome at 5.4 years in extremely preterm infants after intensive neonatal nutritional support. Pediatrics. 2009;123:e101-e109.
4. Georgsdottir I, Erlingsdottir G, Hrafnkelsson B, etal. Disabilities and health of extremely low-birthweight teenagers: a population-based study. Acta Paediatr. 2012;101:518-523.
5. O'Shea TM, Allred EN, Kuban KC, etal. ELGAN Study Investigators. Intraventricular hemorrhage and developmental outcomes at 24 months of age in extremely preterm infants. J Child Neurol. 2012;27:22-29.
6. Kinney HC, Haynes RL, Xu G, etal. Neuron deficit in the white matter and subplate in periventricular leukomalacia. Ann Neurol. 2012;71:397-406.
7. Laughon M, O'Shea MT, Allred EN, ELGAN Study Investigators. Chronic lung disease and developmental delay at 2 years of age in children born before 28 weeks' gestation. Pediatrics. 2009;124:637-648.
8. Rees CM, Pierro A, Eaton S. Neurodevelopmental outcomes of neonates with medically and surgically treated necrotizing enterocolitis. Arch Dis Child Fetal Neonatal Ed. 2007;92:F193-F198.
9. Cooke RW, Foulder-Hughes L. Growth impairment in the very preterm and cognitive and motor performance at 7 years. Arch Dis Child. 2003;88:482-487.
10. Alshaikh B, Yusuf K, Sauve R. Neurodevelopmental outcomes of very low birth weight infants with neonatal sepsis: systematic review and meta-analysis. J Perinatol. 2013;33:558-564.
11. Msall ME, Phelps DL, DiGaudio KM, etal. Severity of neonatal retinopathy of prematurity is predictive of neurodevelopmental functional outcome at age 5.5 years. Pediatrics. 2000;106:998-1005.
12. Ehrenkranz RA, Das A, Wrage LA, etal. Early nutrition mediates the influence of severity of illness on extremely LBW infants. Pediatr Res. 2011;69:522-529.
13. Lafeber HN, Westerbeek EA, van den Berg A, etal. Nutritional factors influencing infections in preterm infants. J Nutr. 2008;138:1813S-1817S.
14. Hellström A, Ley D, Hansen-Pupp I, etal. New insights into the development of retinopathy of prematurity - importance of early weight gain. Acta Paediatr. 2010;99:502-508.
15. AlFaleh K, Anabrees J, Bassler D, etal. Probiotics for prevention of necrotizing enterocolitis in preterm infants. Cochrane Database Syst Rev. 2011;(3):CD005496.
16. Manzoni P, Rinaldi M, Cattani S, etal. Bovine lactoferrin supplementation for prevention of late-onset sepsis in very low-birth-weight neonates: a randomized trial. JAMA. 2009;302:1421-1428.
17. Fanaro S. Which is the ideal target for preterm growth? Minerva Pediatr. 2010;62(3 Suppl 1):77-82.
18. Hanson C, Sundermeier J, Dugick L, etal. Implementation, process, and outcomes of nutrition best practices for infants <1500g. Nutr Clin Pract. 2011;26:614-624.
19. Clark RH, Thomas P, Peabody J. Extrauterine growth restriction remains a serious problem in prematurely born neonates. Pediatrics. 2003;111:986-990.
20. De Curtis M, Rigo J. Extrauterine growth restriction in very-low-birthweight infants. Acta Paediatr. 2004;93:1563-1568.
21. Ehrenkranz RA, Dusick AM, Vohr BR, etal. Growth in the neonatal intensive care unit influences neurodevelopmental and growth outcomes of extremely low birth weight infants. Pediatrics. 2006;117:1253-1261.
22. D'Angio CT, Sinkin RA, Stevens TP, etal. Longitudinal, 15-year follow-up of children born at less than 29 weeks' gestation after introduction of surfactant therapy into a region: neurologic, cognitive, and educational outcomes. Pediatrics. 2002;110:1094-1102.
23. Radmacher PG, Rafail ST, Adamkin DH. Nutrition and growth in VVLBW infants with and without bronchopulmonary dysplasia. Neonatal Intensive Care. 2004;16:22-26.
24. Isaacs EB, Gadian DG, Sabatini S, etal. The efficacy of early human diet on caudate volumes and IQ. Pediatr Res. 2008;63:308-314.
25. Stephens BE, Walden RV, Gargus RA, etal. First-week protein and energy intakes are associated with 18-month developmental outcomes in extremely low birth weight infants. Pediatrics. 2009;123:1337-1343.
26. Taylor SN, Kiger J, Finch C, etal. Fluid, electrolytes, and nutrition: minutes matter. Adv Neonatal Care. 2010;10:248-255.
27. Bonsante F, Iacobelli S, Chantegret C, etal. The effect of parenteral nitrogen and energy on electrolyte balance in the preterm infant. Eur J Clin Nutr. 2011;65:1088-1093.
28. De Curtis M, Rigo J. The nutrition of preterm infants. Early Hum Dev. 2012;88(Suppl 1):S5-S7.
29. Belfort MB, Rifas-Shiman SL, Sullivan T, etal. Infant growth before and after term: effects on neurodevelopment in preterm infants. Pediatrics. 2011;128:899-906.
30. Yang S, Lee BS, Park HW, etal. Effect of high vs standard early parenteral amino acid supplementation on the growth outcomes in very low birth weight infants. JPEN J Parenter Enteral Nutr. 2013;37:327-334.
31. Bulbul A, Okan F, Bulbul L, etal. Effect of low versus high early parenteral nutrition on plasma amino acid profiles in very low birth-weight infants. J Matern Fetal Neonatal Med. 2012;25:770-776.
32. Poindexter BB, Langer JC, Dusick AM, etal. Early provision of parenteral amino acids in extremely low birth weight infants: relation to growth and neurodevelopmental outcome. J Pediatr. 2006;148:300-305.
33. Thureen PJ. Early aggressive nutrition in very preterm infants. Nestle Nutr Workshop Ser Pediatr Program. 2007;59:193-204; discussion 204-208.
34. Verner A, Craig S, McGuire W. Effect of taurine supplementation on growth and development in preterm or low birth weight infants. Cochrane Database Syst Rev. 2007;(4):CD006072.
35. Moe-Byrne T, Wagner JV, McGuire W. Glutamine supplementation to prevent morbidity and mortality in preterm infants. Cochrane Database Syst Rev. 2012;(3):CD001457.
36. Wu G, Jaegar LA, Bazar FW, etal. Arginine deficiency in preterm infants: biochemical mechanisms and nutritional implications. J Nutr Biochem. 2004;15:442-451.
37. Amin HJ, Zamora SA, McMillan DD, etal. Arginine supplementation prevents necrotizing enterocolitis in the premature infant. J Pediatr. 2002;140:425-431.
38. Morgan C. Early amino acid administration in very preterm infants: too little, too late or too much, too soon? Semin Fetal Neonatal Med. 2013;18:160-165.
39. Cormack BE, Bloomfield FH, Dezoete A, etal. Does more protein in the first week of life change outcomes for very low birthweight babies? J Paediatr Child Health. 2011;47:898-903.
40. Senterre T, Rigo J. Reduction in postnatal cumulative nutritional deficit and improvement of growth in extremely preterm infants. Acta Paediatr. 2012;101:e64-e70.
41. Blanco CL, Falck A, Green BK, etal. Metabolic responses to early and high protein supplementation in a randomized trial evaluating the prevention of hyperkalemia in extremely low birth weight infants. J Pediatr. 2008;153:535-540.
42. Bauer J, Gerss J. Longitudinal analysis of macronutrients and minerals in human milk produced by mothers of preterm infants. Clin Nutr. 2011;30:215-220.
43. Thureen PJ, Hay WW, Jr. Intravenous nutrition and postnatal growth of the micropremie. Clin Perinatol. 2000;27:197-219.
44. Clandinin MT, Chappell JE, Leong S, etal. Intrauterine fatty acid accretion rates in human brain: implications for fatty acid requirements. Early Hum Dev. 1980;4:121-129.
45. Lapillonne A, Eleni Trolli SE, Kermorvant-Duchemin E. Postnatal docosahexaenoic acid deficiency is an inevitable consequence of current recommendations and practice in preterm infants. Neonatology. 2010;98:397-403.
46. Eleni Trolli SE, Kermorvant-Duchemin E, Huon C, etal. Early lipid supply and neurological development at one year in very low birth weight (VLBW) preterm infants. Early Hum Dev. 2012;88(Suppl 1):s25-s29.
47. Driscoll DF, Bistrian BR, Demmelmair H, etal. Pharmaceutical and clinical aspects of parenteral lipid emulsions in neonatology. Clin Nutr. 2008;27:497-503.
48. Van Aerde JE, Michaelann SW, Feldman M. Accretion of lipid in the fetus and newborn. In: Polin RA, Fox WW, Abman SH, eds. Fetal and Neonatal Physiology, Vol. 1, 3rd ed. Philadelphia: W.B. Saunders; 2004:400.
49. Clandinin MT, Van Aerde JE, Merkel KL, etal. Growth and development of preterm infants fed infant formulas containing docosahexaenoic acid and arachidonic acid. J Pediatr. 2005;146:461-468.
50. Makrides M, Gibson RA, McPhee AJ, etal. Neurodevelopmental outcome of preterm infants fed high-dose docosahexaenoic acid: a randomized controlled trial. JAMA. 2009;301:175-182.
51. Henriksen C, Haugholt K, Lindgren M, etal. Improved cognitive development among preterm infants attributable to early supplementation of human milk with docosahexaenoic acid and arachidonic acid. Pediatrics. 2008;121:1137-1145.
52. Qawasmi A, Landeros-Weisenberger A, Leckman JF, etal. Meta-analysis of long-chain polyunsaturated fatty acid supplementation of formula and infant cognition. Pediatrics. 2012;129:1141-1149.
53. Levant B, Ozias MK, Jones KA, etal. Differential effects of modulation of docosahexaenoic acid content during development in specific regions of rat brain. Lipids. 2006;41:407-414.
54. Diau GY, Hsieh A, Sarkadi-Nagy E, etal. The influence of long chain polyunsaturate supplementation on docosahexaenoic acid and arachidonic acid in baboon neonate central nervous system. BMC Med. 2005;3:11-23.
55. Hadders-Algra M. Prenatal and early postnatal supplementation with long-chain polyunsaturated fatty acids: neurodevelopmental considerations. Am J Clin Nutr. 2011;94(Suppl):1874S-1879S.
56. Tomsits E, Pataki M, Tolgyesi A, etal. Safety and efficacy of a lipid emulsion containing a mixture of soybean oil, medium-chain triglycerides, olive oil, and fish oil: a randomised, double-blind clinical trial in premature infants requiring parenteral nutrition. J Pediatr Gastroenterol Nutr. 2010;51:514-521.
57. Vlaardingerbroek H, Veldhorst MA, Spronk S, etal. Parenteral lipid administration to very-low-birth-weight infants - early introduction of lipids and use of new lipid emulsions: a systematic review and meta-analysis. Am J Clin Nutr. 2012;96:255-268.
58. Manley BJ, Makrides M, Collins CT, etal. High-dose docosahexaenoic acid supplementation of preterm infants: respiratory and allergy outcomes. Pediatrics. 2011;128:71-77.
59. Martin CR, Dasilva DA, Cluette-Brown JE, etal. Decreased postnatal docosahexaenoic and arachidonic acid blood levels in premature infants are associated with neonatal morbidities. J Pediatr. 2011;159:743-749.
60. Sapieha P, Stahl A, Chen J, etal. 5-Lipoxygenase metabolite 4-HDHA is a mediator of the antiangiogenic effect of ω-3 polyunsaturated fatty acids. Sci Transl Med. 2011;3:69ra12.
61. Pawlik D, Lauterbach R, Turyk E. Fish-oil fat emulsion supplementation may reduce the risk of severe retinopathy in VLBW infants. Pediatrics. 2011;127:223-228.
62. Caplan MS, Russell T, Xiao Y, etal. Effect of polyunsaturated fatty acid (PUFA) supplementation on intestinal inflammation and necrotizing enterocolitis (NEC) in a neonatal rat model. Pediatr Res. 2001;49:647-652.
63. Ohtsuka Y, Okada K, Yamakawa Y, etal. ω-3 fatty acids attenuate mucosal inflammation in premature rat pups. J Pediatr Surg. 2011;46:489-495.
64. Liu Y, Chen F, Odle J, etal. Fish oil enhances intestinal integrity and inhibits TLR4 and NOD2 signaling pathways in weaned pigs after LPS challenge. J Nutr. 2012;142:2017-2024.
65. Smithers LG, Gibson RA, McPhee A, etal. Effect of long-chain polyunsaturated fatty acid supplementation of preterm infants on disease risk and neurodevelopment: a systematic review of randomized controlled trials. Am J Clin Nutr. 2008;87:912-920.
66. Delobel-Ayoub M, Kaminski M, Marret S, etal. Behavioral outcome at 3 years of age in very preterm infants: the EPIPAGE study. Pediatrics. 2006;117:1996-2005.
67. Hille ET, Weisglas-Kuperus N, van Goudoever JB, etal. Functional outcomes and participation in young adulthood for very preterm and very low birth weight infants: the Dutch Project on Preterm and Small for Gestational Age Infants at 19 years of age. Pediatrics. 2007;120:587-595.
68. Anderson PJ, De Luca CR, Hutchinson E, etal. Attention problems in a representative sample of extremely preterm/extremely low birth weight children. Dev Neuropsychol. 2011;36:57-73.
69. Johnson S, Hollis C, Kochhar P, etal. Autism spectrum disorders in extremely preterm children. J Pediatr. 2010;156:525-531.
70. Bourre JM. Dietary omega-3 fatty acids and psychiatry: mood, behaviour, stress, depression, dementia and aging. J Nutr Health Aging. 2005;9:31-38.
71. Meiri G, Bichovsky Y, Belmaker RH. Omega 3 fatty acid treatment in autism. J Child Adolesc Psychopharmacol. 2009;19:449-451.
72. Johnson M, Ostlund S, Fransson G, etal. Omega-3/omega-6 fatty acids for attention deficit hyperactivity disorder: a randomized placebo-controlled trial in children and adolescents. J Atten Disord. 2009;12:394-401.
73. Stevens L, Zhang W, Peck L, etal. EFA supplementation in children with inattention, hyperactivity, and other disruptive disorders. Lipids. 2003;38:1007-1021.
74. Richardson AJ, Puri BK. A randomized double-blind, placebo-controlled study of the effects of supplementation with highly unsaturated fatty acids on ADHD-related symptoms in children with specific learning difficulties. Prog Neuropsychopharmacol Biol Psychiatry. 2002;26:233-239.
75. Richardson AJ, Montgomery P. The Oxford-Durham Study: a randomized, controlled trial of dietary supplementation with fatty acids in children with developmental coordination disorder. Pediatrics. 2005;115:1360-1366.
76. Bouwstra H, Dijck-Brouwer J, Decsi T, etal. Neurologic condition of healthy term infants at 18 months: positive association with venous umbilical DHA status and negative association with umbilical trans-fatty acids. Pediatr Res. 2006;60:324-329.
77. Sabel KG, Strandvik B, Petzold M, etal. Motor, mental and behavioral developments in infancy are associated with fatty acid pattern in breast milk and plasma of premature infants. Prostaglandins Leukot Essent Fatty Acids. 2012;86:183-188.
78. vanGoor SA, Schaafsma A, Erwich JJ, etal. Mildly abnormal general movement quality in infants is associated with higher Mead acid and lower arachidonic acid and shows a U-shaped relation with the DHA/AA ratio. Prostaglandins Leukot Essent Fatty Acids. 2010;82:15-20.
79. Dunstan JA, Simmer K, Dixon G, etal. Cognitive assessment of children at age 2(1/2) years after maternal fish oil supplementation in pregnancy: a randomised controlled trial. Arch Dis Child Fetal Neonatal Ed. 2008;93:F45-F50.
80. Koletzko B, Goulet O, Hunt J, etal. Guidelines on Paediatric Parenteral Nutrition of the European Society of Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) and the European Society for Clinical Nutrition and Metabolism (ESPEN), Supported by the European Society of Paediatric Research (ESPR) J Pediatr Gastroenterol Nutr. 2005;41(suppl 2):S1-87.
81. Lapillonne A, Groh-Wargo S, Gonzalez CH, etal. Lipid needs of preterm infants: updated recommendations. J Pediatr. 2013;162(Suppl 3):S37-S47.
82. McClure RJ. Trophic feeding of the preterm infant. Acta Paediatr Suppl. 2001;90:19-21.
83. Morgan J, Bombell S, McGuire W. Early trophic feeding versus enteral fasting for very preterm or very low birth weight infants. Cochrane Database Syst Rev. 2013;(3):CD000504.
84. Sullivan S, Schanler RJ, Kim JH, etal. An exclusively human milk-based diet is associated with a lower rate of necrotizing enterocolitis than a diet of human milk and bovine milk-based products. J Pediatr. 2010;156:562-567.
85. Vohr BR, Poindexter BB, Dusick AM, etal. Persistent beneficial effects of breast milk ingested in the neonatal intensive care unit on outcomes of extremely low birth weight infants at 30 months of age. Pediatrics. 2007;120:e953-e959.
86. Feldman R, Eidelman AI. Direct and indirect effects of breast milk on the neurobehavioral and cognitive development of premature infants. Dev Psychobiol. 2003;43:109-119.
87. Porcelli PJ, Weaver RG Jr. The influence of early postnatal nutrition on retinopathy of prematurity in extremely low birth weight infants. Early Hum Dev. 2010;86:391-396.
88. Rozé JC, Darmaun D, Boquien CY, etal. The apparent breastfeeding paradox in very preterm infants: relationship between breast feeding, early weight gain and neurodevelopment based on results from two cohorts, EPIPAGE and LIFT. BMJ Open. 2012;2:e000834.
89. Bertino E, Arslanoglu S, Martano C, etal. Biological, nutritional and clinical aspects of feeding preterm infants with human milk. J Biol Regul Homeost Agents. 2012;26(3 Suppl):9-13.
90. Kuschel CA, Harding JE. Multicomponent fortified human milk for promoting growth in preterm infants. Cochrane Database Syst Rev. 2004;(1):CD000343.
91. Arslanoglu S, Moro G, Ziegler E. Adjustable fortification of human milk fed to preterm infants: does it make a difference? J Perinatol. 2006;26:614-621.
92. Arslanoglu S, Moro GE, Ziegler EE. The WAPM Working Group on Nutrition. Optimization of human milk fortification for preterm infants: new concepts and recommendations. J Perinat Med. 2010;38:233-238.
93. Biasini A, Marvulli L, Neri E, etal. Growth and neurological outcome in ELBW preterms fed with human milk and extra-protein supplementation as routine practice: do we need further evidence? J Matern Fetal Neonatal Med. 2012;25:72-74.
94. Biasini A, Neri C, China MC, etal. Higher protein intake strategies in human milk fortification for preterms infants feeding. Auxological and neurodevelopmental outcome. J Biol Regul Homeost Agents. 2012;26(3 Suppl):43-47.
95. Di Natale C, Coclite E, Di Ventura L, etal. Fortification of maternal milk for preterm infants. J Matern Fetal Neonatal Med. 2011;24(Suppl):41-43.
96. Wang Y, Hoenig JD, Malin KJ, etal. 16S rRNA gene-based analysis of fecal microbiota from preterm infants with and without necrotizing enterocolitis. ISME J. 2009;3:944-954.
97. Guthmann F, Kluthe C, Bührer C. Probiotics for prevention of necrotising enterocolitis: an updated meta-analysis. [In German] Klin Padiatr. 2010;222:284-290.
98. Chiu HY, Hsieh HY, Lin HY, etal. Efficacy of different probiotic supplements in preterm very low birth weight infants to prevent necrotizing enterocolitis or death: a meta-analysis [abstract]. 6th Congress of Asian Society for Pediatric Research & 51st Annual Meeting of Taiwan Pediatric Association 2010:15-18.
99. Wu SF, Chiu HY, Chen AC, etal. Efficacy of different probiotic combinations on death and necrotizing enterocolitis in a premature rat model. J Pediatr Gastroenterol Nutr. 2013;57:23-28.
100. Fernández-Carrocera LA, Solis-Herrera A, Cabanillas-Ayón M, etal. Double-blind, randomised clinical assay to evaluate the efficacy of probiotics in preterm newborns weighing less than 1500g in the prevention of necrotising enterocolitis. Arch Dis Child Fetal Neonatal Ed. 2012;98:F5-F9.
101. Chou IC, Kuo HT, Chang JS, etal. Lack of effects of oral probiotics on growth and neurodevelopmental outcomes in preterm very low birth weight infants. J Pediatrics. 2010;156:393-396.
102. Sari FN, Eras Z, Dizdar EA, etal. Do oral probiotics affect growth and neurodevelopmental outcomes in very low-birth-weight preterm infants? Am J Perinatol. 2012;29:579-586.
103. Neu J, Walker W. Necrotizing enterocolitis. N Engl J Med. 2011;364:255-264.
104. Fallon EM, Nehra D, Potemkin AK, etal. A.S.P.E.N. clinical guidelines: nutrition support of neonatal patients at risk for necrotizing enterocolitis. JPEN J Parenter Enteral Nutr. 2012;36:506-523.
105. Kitajima H, Sumida Y, Tanaka R, etal. Early administration of Bifidobacterium breve to preterm infants: randomised controlled trial. Arch Dis Child Fetal Neonatal Ed. 1997;76:F101-F107
106. Manzoni P, Stolfi I, Messner H, etal. Bovine lactoferrin prevents invasive fungal infections in very low birth weight infants: a randomized controlled trial. Pediatrics. 2012;129:116-123.
107. Eriksson JG, Forsén T, Tuomilehto J, etal. Early growth and coronary heart disease in later life: longitudinal study. BMJ. 2001;322:949-953.
108. Singhal A, Cole TJ, Fewtrell M, etal. Is slower early growth beneficial for long-term cardiovascular health? Circulation. 2004;109:1108-1113.
109. Miles HL, Hofman PL, Cutfield WS. Fetal origins of adult disease: a paediatric perspective. Rev Endocr Metab Disord. 2005;6:261-268.
110. Lapillonne A, Griffin IJ. Feeding preterm infants today for later metabolic and cardiovascular outcomes. J Pediatr. 2013;162(3 Suppl):S7-S16.